Human Molecular Genetics Advance Access originally published online on July 14, 2009
Human Molecular Genetics 2009 18(20):3795-3804; doi:10.1093/hmg/ddp321
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tissue-specific alternative splicing of TCF7L2
1 Genome Technology Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA, 2 Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 8717 Grovemont Circle, Bethesda, MD 20892, USA, 3 Lillehei Heart Institute, Department of Medicine and 4 Developmental Biology Center, University of Minnesota, Minneapolis, MN 55455, USA, 5 Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden, 6 Center for Statistical Genetics, Department of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI 48109, USA, 7 Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA and 8 Children's National Medical Center, Center for Genetic Medicine Research (CGMR), Washington, DC 20010, USA
* To whom correspondence should be addressed. Tel: +1 3014435297; Fax: +1 3014433234; Email: prokuninal{at}mail.nih.gov
Received June 15, 2009; Accepted July 10, 2009
Common variants in the transcription factor 7-like 2 (TCF7L2) gene have been identified as the strongest genetic risk factors for type 2 diabetes (T2D). However, the mechanisms by which these non-coding variants increase risk for T2D are not well-established. We used 13 expression assays to survey mRNA expression of multiple TCF7L2 splicing forms in up to 380 samples from eight types of human tissue (pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell lines) and observed a tissue-specific pattern of alternative splicing. We tested whether the expression of TCF7L2 splicing forms was associated with single nucleotide polymorphisms (SNPs), rs7903146 and rs12255372, located within introns 3 and 4 of the gene and most strongly associated with T2D. Expression of two splicing forms was lower in pancreatic islets with increasing counts of T2D-associated alleles of the SNPs: a ubiquitous splicing form (P = 0.018 for rs7903146 and P = 0.020 for rs12255372) and a splicing form found in pancreatic islets, pancreas and colon but not in other tissues tested here (P = 0.009 for rs12255372 and P = 0.053 for rs7903146). Expression of this form in glucose-stimulated pancreatic islets correlated with expression of proinsulin (r2 = 0.84–0.90, P < 0.00063). In summary, we identified a tissue-specific pattern of alternative splicing of TCF7L2. After adjustment for multiple tests, no association between expression of TCF7L2 in eight types of human tissue samples and T2D-associated genetic variants remained significant. Alternative splicing of TCF7L2 in pancreatic islets warrants future studies. GenBank Accession Numbers: FJ010164 [GenBank] –FJ010174.